173 related articles for article (PubMed ID: 17155985)
21. [What is the clinical practice of partial nephrectomy in France?].
Bernhard JC; Ferriere JM; Crepel M; Wallerand H; Bellec L; Lacroix B; Lopes D; Albouy B; Robert G; Ravaud A; Colombel M; Tostain J; Pfister C; Soulie M; Salomon L; De La Taille A; Pasticier G; Abbou CC; Manunta A; Guille F; Patard JJ
Prog Urol; 2008 Jul; 18(7):428-34. PubMed ID: 18602602
[TBL] [Abstract][Full Text] [Related]
22. Nephron-sparing surgery for renal cell carcinoma in the solitary kidney.
Berdjis N; Hakenberg OW; Novotny V; Manseck A; Oehlschläger S; Wirth MP
Scand J Urol Nephrol; 2007; 41(1):10-3. PubMed ID: 17366096
[TBL] [Abstract][Full Text] [Related]
23. Is there a benefit to frozen section analysis at the time of partial nephrectomy?
Sterious SN; Simhan J; Smaldone MC; Tsai KJ; Canter D; Wameedh E; Li T; Helstrom J; Viterbo R; Chen DY; Greenberg RE; Kutikov A; Al-Saleem T; Uzzo RG
Can J Urol; 2013 Jun; 20(3):6778-84. PubMed ID: 23783047
[TBL] [Abstract][Full Text] [Related]
24. Transitional cell carcinomas of the renal pelvis and the ureter: comparative demographic characteristics, pathological grade and stage and 5-year survival in a Taiwanese population.
Tan LB; Chang LL; Cheng KI; Huang CH; Kwan AL
BJU Int; 2009 Feb; 103(3):312-6. PubMed ID: 18782312
[TBL] [Abstract][Full Text] [Related]
25. Morbidity and clinical outcome of nephron-sparing surgery in relation to tumour size and indication.
Patard JJ; Pantuck AJ; Crepel M; Lam JS; Bellec L; Albouy B; Lopes D; Bernhard JC; Guillé F; Lacroix B; De La Taille A; Salomon L; Pfister C; Soulié M; Tostain J; Ferriere JM; Abbou CC; Colombel M; Belldegrun AS
Eur Urol; 2007 Jul; 52(1):148-54. PubMed ID: 17240036
[TBL] [Abstract][Full Text] [Related]
26. [The impact of partial nephrectomy on morbidity and on long-term oncological outcomes].
Rouach Y; Timsit MO; Lebret T; Fontaine E; Yonneau L; Herve JM; Botto H; Thiounn N; Mejean A
Prog Urol; 2009 Jul; 19(7):481-6. PubMed ID: 19559379
[TBL] [Abstract][Full Text] [Related]
27. Impact of clinical variables on predicting disease-free survival of patients with surgically resected renal cell carcinoma.
Brookman-Amissah S; Kendel F; Spivak I; Pflanz S; Roigas J; Klotz T; May M
BJU Int; 2009 May; 103(10):1375-80. PubMed ID: 19040527
[TBL] [Abstract][Full Text] [Related]
28. Intermediate-term prospective results of radiofrequency-assisted laparoscopic partial nephrectomy: a non-ischaemic coagulative technique.
Zeltser IS; Moonat S; Park S; Anderson JK; Cadeddu JA
BJU Int; 2008 Jan; 101(1):36-8. PubMed ID: 17850367
[TBL] [Abstract][Full Text] [Related]
29. Incidentally discovered renal masses: oncological and perioperative outcomes in patients with delayed surgical intervention.
Rais-Bahrami S; Guzzo TJ; Jarrett TW; Kavoussi LR; Allaf ME
BJU Int; 2009 May; 103(10):1355-8. PubMed ID: 19239459
[TBL] [Abstract][Full Text] [Related]
30. Partial nephrectomy for renal urothelial tumors: clinical update.
Goel MC; Matin SF; Derweesh I; Levin H; Streem S; Novick AC
Urology; 2006 Mar; 67(3):490-5. PubMed ID: 16527564
[TBL] [Abstract][Full Text] [Related]
31. [Do broader indications for partial nephrectomy result in excess morbidity?].
Verhoest G; Crepel M; Bernhard JC; Bellec L; Albouy B; Lopes D; Lacroix B; De La Taille A; Salomon L; Pfister C; Soulié M; Tostain J; Ferrière JM; Abbou CC; Colombel M; Vincendeau S; Bensalah K; Manunta A; Guillé F; Patard JJ
Prog Urol; 2008 Apr; 18(4):207-13. PubMed ID: 18501300
[TBL] [Abstract][Full Text] [Related]
32. Cytoreductive nephrectomy for metastatic renal cell carcinoma with nonclear cell histology.
Kassouf W; Sanchez-Ortiz R; Tamboli P; Tannir N; Jonasch E; Merchant MM; Matin S; Swanson DA; Wood CG
J Urol; 2007 Nov; 178(5):1896-900. PubMed ID: 17868729
[TBL] [Abstract][Full Text] [Related]
33. Laparoscopic partial nephrectomy at the Mayo Clinic Arizona: follow-up surveillance of positive margin disease.
Desai PJ; Andrews PE; Ferrigni RG; Castle EP
Urology; 2008 Feb; 71(2):283-6. PubMed ID: 18308104
[TBL] [Abstract][Full Text] [Related]
34. Robotic-assisted laparoscopic partial nephrectomy: surgical technique and clinical outcomes at 1 year.
Ho H; Schwentner C; Neururer R; Steiner H; Bartsch G; Peschel R
BJU Int; 2009 Mar; 103(5):663-8. PubMed ID: 18990172
[TBL] [Abstract][Full Text] [Related]
35. Bilateral synchronous sporadic renal cell carcinoma: surgical management, oncological and functional outcomes.
Pahernik S; Cudovic D; Roos F; Melchior SW; Thüroff JW
BJU Int; 2007 Jul; 100(1):26-9. PubMed ID: 17552949
[TBL] [Abstract][Full Text] [Related]
36. Phyllodes tumor of the breast: stromal overgrowth and histological classification are useful prognosis-predictive factors for local recurrence in patients with a positive surgical margin.
Taira N; Takabatake D; Aogi K; Ohsumi S; Takashima S; Nishimura R; Teramoto N
Jpn J Clin Oncol; 2007 Oct; 37(10):730-6. PubMed ID: 17932112
[TBL] [Abstract][Full Text] [Related]
37. Baseline renal function, ischaemia time and blood loss predict the rate of renal failure after partial nephrectomy.
Jeldres C; Bensalah K; Capitanio U; Zini L; Perrotte P; Suardi N; Tostain J; Valeri A; Descotes JL; Rambeaud JJ; de La Taille A; Salomon L; Abbou C; Patard JJ; Karakiewicz PI
BJU Int; 2009 Jun; 103(12):1632-5. PubMed ID: 19545272
[TBL] [Abstract][Full Text] [Related]
38. Postoperative surveillance for renal cell carcinoma: a multifactorial histological subtype specific protocol.
Siddiqui SA; Frank I; Cheville JC; Lohse CM; Leibovich BC; Blute ML
BJU Int; 2009 Sep; 104(6):778-85. PubMed ID: 19338559
[TBL] [Abstract][Full Text] [Related]
39. Outcomes following partial nephrectomy by tumor size.
Crispen PL; Boorjian SA; Lohse CM; Sebo TS; Cheville JC; Blute ML; Leibovich BC
J Urol; 2008 Nov; 180(5):1912-7. PubMed ID: 18801543
[TBL] [Abstract][Full Text] [Related]
40. Importance of surgical margins in the management of renal cell carcinoma.
Lam JS; Bergman J; Breda A; Schulam PG
Nat Clin Pract Urol; 2008 Jun; 5(6):308-17. PubMed ID: 18477995
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
